neobookRx

Cutaneous Haemangiomas

Description Diagnostic criteria  General and supportive measures Referral ICD-10 code:  D18.0 DESCRIPTION Benign tumours of the vascular endothelium that may be classified as either congenital or infantile. They are characterised by abnormal proliferation of endothelial cells and abnormal blood vessel architecture. Congenital haemangiomas: Fully grown at birth, and are either rapidly in

Description

Diagnostic criteria 

General and supportive measures

Referral


ICD-10 code: D18.0

DESCRIPTION

Benign tumours of the vascular endothelium that may be classified as either congenital or infantile. They are characterised by abnormal proliferation of endothelial cells and abnormal blood vessel architecture.

  • Congenital haemangiomas: Fully grown at birth, and are either rapidly involuting or non-involuting.
  • Infantile haemangiomas: Usually appear before 4 weeks of age and continue to grow until 5 months.

 DIAGNOSTIC CRITERIA

  • Most haemangiomas can be diagnosed clinically.

GENERAL AND SUPPORTIVE MEASURES

  • Counselling to assist the patient in dealing with the condition.

REFERRAL

  • Life-threatening haemangiomas (airways), function-threatening haemangiomas, ulcerating lesions, multiple lesions (> 5 lesions); for consideration of propranolol.
  • Diagnostic uncertainty.
  • Failure to respond to therapy.
  • Peri-ocular haemangioma.
  • Suspected airway haemangioma.
  • Large segmental haemangioma on the face, neck or vital organ for echocardiogram.
  • Propranolol pre-treatment evaluation reveals cardiac or pulmonary abnormalities.

Standard Treatment Guidelines and Essential Medicines List for South Africa, Hospital Level, Paediatrics, 2023 Edition

Chapter 5: Dermatology,  5.5. Vesicles And Pustules,  5.5.4 Cutaneous Haemangiomas

Drugs mentioned

ICD-10 codes

NeoHealth® ID 34779 · updated 4/11/2023